AT
DGX icon

Adelphi Trust’s Quest Diagnostics DGX Stock Holding History

Adelphi Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$295K Buy
1,267
+37
+3% +$8.55K 0.19% 95
2026
Q2 		$261K Buy
1,230
+185
+18% +$36.3K 0.17% 99
2026
Q1 		$205K Buy
+1,045
New +$203K 0.17% 103

Other funds holding DGX

EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $660M AUM 18.73% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.07B AUM 21.73% 1-Year Est. Return
SVWA
Sarver Vrooman Wealth Advisors Kansas City, Missouri $170M AUM 4.33% 1-Year Est. Return

Adelphi Trust's DGX Position: Q3 2026 in Review

Adelphi Trust increased its Quest Diagnostics (DGX) stake by 3% in Q3 2026, buying an estimated $8.55K and bringing the position to 1,267 shares worth $295K. The position accounts for 0.19% of the portfolio, ranked #95.

Adelphi Trust first reported a position in DGX in Q1 2026 and has held it in 3 quarters since. 15 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Adelphi Trust held 1,267 shares of Quest Diagnostics worth $295K as of Q3 2026.
  • Adelphi Trust bought 37 Quest Diagnostics shares in Q3 2026, an estimated $8.55K.
  • Quest Diagnostics made up 0.19% of Adelphi Trust's portfolio in Q3 2026, its #95 holding.
  • Adelphi Trust first reported a position in Quest Diagnostics in Q1 2026 and has held it in 3 quarters since.
  • 15 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Adelphi Trust's 13F filing for Q3 2026, filed 5 Oct 2026.